NCT01138280

Brief Summary

Hemodialysis (HD) may lead to increase inflammatory response through a number of mechanisms. HD-related inflammation is mainly due to underlying kidney disease, coexisting comorbidities, uremia per se, dialyzer membrane biocompatibility and contaminated dialysis fluid. Accordingly, HD patients are chronically exposed to microinflammation as a result of blood-membrane interaction and dialysis fluid contamination. Among these factors, biofilm formation and contaminated dialysis fluid are closely related to enhanced immune activation in HD patients. Furthermore, only dialysis fluid quality is controllable and preventable. Therefore, to reduce the cardiovascular (CV) events and improve the outcome, it prompts us to conduct a prospective randomized controlled study to explore whether heat disinfection link in HD water treatment system can effectively prevent biofilm formation, to ensure the dialysis fluid purity, and subsequently to improve the patient outcome, in terms of CV events and mortality.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
540

participants targeted

Target at P75+ for phase_4

Timeline
Completed

Started Mar 2005

Longer than P75 for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2005

Completed
4.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2009

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2010

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

May 25, 2010

Completed
13 days until next milestone

First Posted

Study publicly available on registry

June 7, 2010

Completed
Last Updated

June 7, 2010

Status Verified

January 1, 2005

Enrollment Period

4.8 years

First QC Date

May 25, 2010

Last Update Submit

June 4, 2010

Conditions

Keywords

biofilm formationproinflammatory cytokineshigh sensitive c reactive proteincardiovascular eventsoverall mortalityhemodialysis

Outcome Measures

Primary Outcomes (2)

  • CV events, CV

    5 years

  • all-cause mortality

    5 years

Secondary Outcomes (3)

  • biofilm formation

    5 years

  • endotoxin level of dialysis water

    5 years

  • pro-inflammatory cytokine levels in serum

    5 years

Study Arms (2)

Heat disinfection

EXPERIMENTAL

Experimental arm: Heat disinfection link to RO water treatment system and piping system to dialysis machine

Device: CWP 103H (Gambro, Sweden): a heat disinfection device

Conventional RO water treatment

NO INTERVENTION

Placebo arm: conventional chemical disinfection link to RO water treatment system.

Interventions

Heat disinfection can increase temperature to 95c in the RO water treatment system and then in the piping system link to dialysis machines in each hemodialysis center per night

Also known as: Heat disinfection (temperature up to 95 c), RO water treatment system, piping system, dialysis machine
Heat disinfection

Eligibility Criteria

Age20 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age over 20 years and duration of HD over 3 months, and clinically stable

You may not qualify if:

  • patients with acute infection, malignancy, active autoimmune disease, GI bleeding or blood loss; systemic inflammatory disease; life expectancy less than 3 months, and unwilling to participate in this study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Taipei Veterans General Hospital

Taipei, 11217, Taiwan

Location

MeSH Terms

Interventions

Kidneys, Artificial

Intervention Hierarchy (Ancestors)

Artificial OrgansSurgical EquipmentEquipment and Supplies

Study Officials

  • Der-Cherng Tarng, MD, PhD

    Taipei Veterans General Hospital, Taiwan

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV

Study Record Dates

First Submitted

May 25, 2010

First Posted

June 7, 2010

Study Start

March 1, 2005

Primary Completion

December 1, 2009

Study Completion

March 1, 2010

Last Updated

June 7, 2010

Record last verified: 2005-01

Locations